Yang Ping-Chang, Liu Tao, Wang Bin-Quan, Zhang Tao-Yuan, An Zi-Yuan, Zheng Peng-Yuan, Tian Dao-Fa
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
BMC Gastroenterol. 2005 Sep 6;5:28. doi: 10.1186/1471-230X-5-28.
During clinical practice, we noticed that some patients with both ulcerative colitis (UC) and chronic rhinosinusitis (CRS) showed amelioration of UC after treatment of CRS. This study was designed to identify a possible association between CRS and UC.
Thirty-two patients with both CRS and UC received treatment with functional endoscopic sinus surgery (FESS) for CRS. Clinical symptom scores for CRS and UC, as well as serum levels of anti-Staphylococcal enterotoxin B (SEB) were evaluated at week 0 and week 12. Sinus wash fluid SEB content was measured with enzyme-linked immunosorbent assay (ELISA). The surgically removed tissues were cultured to identify growth of Staphylococcus. aureus (S. aureus). Immunohistochemistry was employed to identify anti-SEB positive cells in the colonic mucosa. Colonic biopsies were obtained and incubated with SEB. Mast cell activation in the colonic mucosa in response to incubation with SEB was observed with electron microscopy and immunoassay.
The clinical symptom scores of CRS and UC severe scores (UCSS) were significantly reduced in the UC-CRS patients after FESS. The number of cultured S. aureus colonies from the surgically removed sinus mucosa significantly correlated with the decrease in UCSS. High levels of SEB were detected in the sinus wash fluids of the patients with UC-CRS. Histamine and tryptase release was significantly higher in the culture supernate in the patients with UC-CRS than the patients with UC-only and normal controls. Anti-SEB positive cells were located in the colonic mucosa.
The pathogenesis of UC in some patients may be associated with their pre-existing CRS by a mechanism of swallowing sinusitis-derived SEB. We speculate that SEB initiates inappropriate immune reactions and inflammation in the colonic mucosa that further progresses to UC.
在临床实践中,我们注意到一些同时患有溃疡性结肠炎(UC)和慢性鼻-鼻窦炎(CRS)的患者在CRS治疗后UC病情有所改善。本研究旨在确定CRS与UC之间可能存在的关联。
32例同时患有CRS和UC的患者接受了针对CRS的功能性鼻内镜鼻窦手术(FESS)治疗。在第0周和第12周评估CRS和UC的临床症状评分以及抗葡萄球菌肠毒素B(SEB)的血清水平。采用酶联免疫吸附测定(ELISA)测量鼻窦冲洗液中的SEB含量。对手术切除的组织进行培养以鉴定金黄色葡萄球菌(S. aureus)的生长情况。采用免疫组织化学方法鉴定结肠黏膜中抗SEB阳性细胞。获取结肠活检组织并与SEB一起孵育。通过电子显微镜和免疫测定观察结肠黏膜中肥大细胞对与SEB孵育的反应。
FESS治疗后,UC-CRS患者的CRS临床症状评分和UC严重程度评分(UCSS)显著降低。手术切除的鼻窦黏膜培养出的金黄色葡萄球菌菌落数量与UCSS的降低显著相关。在UC-CRS患者的鼻窦冲洗液中检测到高水平的SEB。UC-CRS患者培养上清液中的组胺和类胰蛋白酶释放显著高于仅患有UC的患者和正常对照组。抗SEB阳性细胞位于结肠黏膜中。
部分患者UC的发病机制可能与先前存在的CRS有关,其机制为吞咽源自鼻窦炎的SEB。我们推测SEB引发结肠黏膜中不适当的免疫反应和炎症,进而发展为UC。